AU Stock MarketDetailed Quotes

SNT Syntara Ltd

Watchlist
  • 0.066
  • +0.001+1.54%
20min DelayTrading May 8 14:35 AET
107.20MMarket Cap-4.13P/E (Static)

About Syntara Ltd Company

Syntara Ltd is a clinical-stage drug development company working to bring new and life-changing treatments to patients in need. It is targeting extracellular matrix dysfunction with its expertise in amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The company has various drug candidates in its pipeline such as SNT-5505, SNT-4728, SNT-5382, and SNT-8370 as a potential treatment for cancer, skin scarring, and neuroinflammation.

Company Profile

SymbolSNT
Company NameSyntara Ltd
Founded1998
MarketASX
Employees21
Fiscal Year Ends06-30
Address20 Rodborough Road Unit 2
CitySydney
CountryAustralia
Zip Code2086
Phone+61 287601480
Share RegistryBOARDROOM PTY LIMITED LEVEL 8, 210 GEORGE STREET, SYDNEY, NSW, AUSTRALIA, 2000 (02) 9290 9600

Company Executives

  • Name
  • Position
  • Salary
  • Gary Phillips
  • Chief Executive Officer,Managing Director
  • --
  • Kathleen Mary Metters
  • Non-Executive Director,Non-Executive Chairman
  • --
  • Waradana Malitha Hashan De Silva
  • Non-Executive Director
  • --
  • Simon Green
  • Non-Executive Director
  • --

Market Insights

Warren Buffett Portfolio Warren Buffett Portfolio

Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.

Unlock Now

Discussing

Berkshire 2025 highlights: Stepping aside as CEO, trade and market volatility
$Berkshire Hathaway-A (BRK.A.US)$ held its highly anticipated annual shareholders meeting Saturday. Here are some key takeaways from the eve Show More